Visium Asset’s $1.46 Billion Invested in These Quarterly Stock Holdings

Wall St. Watchdog reveals information regarding Visium Asset Management’s top holdings for the quarter ending September 30th, 2011. The firm held 384 stocks at the end of the quarter with an aggregate market value of $1.461 billion.

  • Medicis Pharmaceutical Corp. (NYSE:MRX): On 06/30/2011, Visium Asset Management reported holding 4,000,000 shares with a market value of $152,679,993. This comprised 7.4% of the total portfolio. On 09/30/2011, Visium Asset Management reported holding 4,250,000 shares with a market value of $155,039,998. This comprised 10.61% of the total portfolio. The net change in shares for this position over the two quarters is 250,000. About Company: Medicis Pharmaceutical Corporation provides pharmaceuticals focusing on the treatment of dermatological, pediatric, and podiatric conditions, as well as aesthetics medicine. The Company has branded prescription products in therapeutic categories such as acne, asthma, eczema, fungal infections, hyperpigmentation, photoaging, psoriasis, and rosacea.
  • Aetna Inc. (NYSE:AET): On 06/30/2011, Visium Asset Management reported holding 1,548,395 shares with a market value of $68,268,736. This comprised 3.31% of the total portfolio. On 09/30/2011, Visium Asset Management reported holding 2,880,000 shares with a market value of $104,659,200. This comprised 7.16% of the total portfolio. The net change in shares for this position over the two quarters is 1,331,605. About Company: Aetna Inc. is a diversified health care benefits company that provides healthcare and related benefits, serving health care members, dental members, and group insurance customers. The Company offers medical, pharmacy, dental, behavioral health, group life and disability plans, and medical management capabilities and health care management services for Medicaid plans.
  • Allergan Inc. (NYSE:AGN): On 06/30/2011, Visium Asset Management reported holding 1,050,000 shares with a market value of $87,412,500. This comprised 4.24% of the total portfolio. On 09/30/2011, Visium Asset Management reported holding 1,000,000 shares with a market value of $82,379,997. This comprised 5.64% of the total portfolio. The net change in shares for this position over the two quarters is -50,000. About Company: Allergan, Inc. is a multi-specialty health care company that discovers, develops and commercializes pharmaceuticals, biologics and medical devices. The Company develops products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological and other specialty markets in countries around the world.
  • Grifols S.a. – American Depositary Shares (GRFS): On 06/30/2011, Visium Asset Management reported holding 7,551,404 shares with a market value of $56,711,046. This comprised 2.75% of the total portfolio. On 09/30/2011, Visium Asset Management reported holding 10,680,593 shares with a market value of $68,248,988. This comprised 4.67% of the total portfolio. The net change in shares for this position over the two quarters is 3,129,189.
  • Unitedhealth Group Inc. (NYSE:UNH): On 06/30/2011, Visium Asset Management reported holding 27,498 shares with a market value of $1,418,347. This comprised 0.07% of the total portfolio. On 09/30/2011, Visium Asset Management reported holding 1,252,667 shares with a market value of $57,773,001. This comprised 3.95% of the total portfolio. The net change in shares for this position over the two quarters is 1,225,169. About Company: UnitedHealth Group Incorporated owns and manages organized health systems in the United States and internationally. The Company provides employers products and resources to plan and administer employee benefit programs. UnitedHealth also serves the health needs of older Americans, provides specialized care services, and provides health care information and research to providers and payers.
  • Humana Inc. (NYSE:HUM): On 06/30/2011, Visium Asset Management reported holding 0 shares. On 09/30/2011, Visium Asset Management reported holding 589,573 shares with a market value of $42,879,646. This comprised 2.93% of the total portfolio. The net change in shares for this position over the two quarters is 589,573. About Company: Humana Inc. is a managed health care company with medical members located in the United States and Puerto Rico. The Company offers coordinated health care through health maintenance organizations, preferred provider organizations, point-of-service plans, and administrative services products. Humana offers its products to employer groups, government-sponsored plans, and individuals.
  • Valeant Pharmaceuticals International (NYSE:VRX): On 06/30/2011, Visium Asset Management reported holding 150,000 shares with a market value of $7,794,000. This comprised 0.38% of the total portfolio. On 09/30/2011, Visium Asset Management reported holding 1,150,000 shares with a market value of $42,687,999. This comprised 2.92% of the total portfolio. The net change in shares for this position over the two quarters is 1,000,000. About Company: Valeant Pharmaceuticals International, Inc. develops and distributes drugs. The Company develops drugs for unmet medical needs in central nervous system disorders; and distributes generic and branded generic drugs in Latin America and Eastern Europe.
  • Intermune Inc. (NASDAQ:ITMN): On 06/30/2011, Visium Asset Management reported holding 2,106,412 shares with a market value of $75,514,867. This comprised 3.66% of the total portfolio. On 09/30/2011, Visium Asset Management reported holding 2,028,953 shares with a market value of $40,984,852. This comprised 2.81% of the total portfolio. The net change in shares for this position over the two quarters is -77,459. About Company: InterMune, Inc. is a biopharmaceutical company. The Company develops therapies for hepatology and pulmonology, including treatments for severe, malignant osteopetrosis and chronic granulomatous disease
  • Cigna Corporation (NYSE:CI): On 06/30/2011, Visium Asset Management reported holding 600,000 shares with a market value of $30,858,000. This comprised 1.5% of the total portfolio. On 09/30/2011, Visium Asset Management reported holding 965,000 shares with a market value of $40,472,099. This comprised 2.77% of the total portfolio. The net change in shares for this position over the two quarters is 365,000. About Company: CIGNA Corporation, through its subsidiaries, provides group life and health insurance, managed care products and services, retirement products and services, and individual financial services worldwide. The Company also sells individual life and health insurance and annuity products in selected international locations.
  • Biogen Idec Inc. (NASDAQ:BIIB): On 06/30/2011, Visium Asset Management reported holding 17,219 shares with a market value of $1,841,055. This comprised 0.09% of the total portfolio. On 09/30/2011, Visium Asset Management reported holding 385,993 shares with a market value of $35,955,249. This comprised 2.46% of the total portfolio. The net change in shares for this position over the two quarters is 368,774. About Company: Biogen Idec Inc. develops, manufactures, and commercializes therapies, focusing on neurology, oncology, and immunology. The Company’s products addresses diseases such as multiple sclerosis, non-Hodgkin’s lymphoma, rheumatoid arthritis, crohn’s disease, and psoriasis.

(Note: Data regarding Visium Asset Management’s stock holdings are sourced from whalewisdom.com. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>